Your browser doesn't support javascript.
loading
Mostrar: 20 | 50 | 100
Resultados 1 - 6 de 6
Filtrar
Mais filtros










Base de dados
Intervalo de ano de publicação
1.
Lik Sprava ; (1-2): 48-55, 2015.
Artigo em Ucraniano | MEDLINE | ID: mdl-26118027

RESUMO

For the purpose of definition of features immunohistochemical expression of protein Ubiquitin in peritumoral testicular tissue, which can be characterised as precancerous changes, the 40 patients with testicular germ cell tumors are investigated. In peritumoral testicular tissue in patients with disturbance of spermatogenesis. which make 95 %, it is taped: intensifying in seminiferous tubules of ubiquitination processes, testifying about intensive proteolysis of considerable quantity of the damaged intracellular proteins, occurrence of atypical germ cells (TIN), which differ from normal spermatogenesis cells authentically lower of nuclear and cytoplasmatic expression of protein Ubiquitin, and also disturbance of ubiquitination processes in Leydig cells in the form of intensifying of cytoplasmatic expression and total disappearance of nuclear expression of protein Ubiquitin. The received results testify to the important role of structural and functional disturbances of ubiquitin-proteolysis system components at the initial stages of testicular tissue carcinogenesis.


Assuntos
Carcinogênese/genética , Células Intersticiais do Testículo/metabolismo , Neoplasias Embrionárias de Células Germinativas/genética , Túbulos Seminíferos/metabolismo , Espermatozoides/metabolismo , Neoplasias Testiculares/genética , Ubiquitina/genética , Adolescente , Adulto , Carcinogênese/metabolismo , Carcinogênese/patologia , Núcleo Celular/metabolismo , Núcleo Celular/patologia , Citoplasma/metabolismo , Citoplasma/patologia , Expressão Gênica , Humanos , Imuno-Histoquímica , Células Intersticiais do Testículo/patologia , Masculino , Pessoa de Meia-Idade , Neoplasias Embrionárias de Células Germinativas/diagnóstico , Neoplasias Embrionárias de Células Germinativas/patologia , Neoplasias Embrionárias de Células Germinativas/cirurgia , Orquiectomia , Proteólise , Túbulos Seminíferos/patologia , Túbulos Seminíferos/cirurgia , Espermatogênese/genética , Espermatozoides/patologia , Neoplasias Testiculares/diagnóstico , Neoplasias Testiculares/patologia , Neoplasias Testiculares/cirurgia , Ubiquitina/metabolismo , Ubiquitinação
2.
Exp Oncol ; 36(4): 276-8, 2014 Dec.
Artigo em Inglês | MEDLINE | ID: mdl-25537224

RESUMO

UNLABELLED: The androgen-suppressive therapy (AST) in patients with prostate cancer (PC) may dramatically affect the bone mineral density (BMD), which puts patients at risk of severe adverse effects, such as weight-bearing bone fractures. AIM: To study the effect of AST on BMD in patients with non-metastatic hormone-sensitive PC treated with intermittent hormonal therapy, and effect of different total testosterone level on BMD. MATERIALS AND METHODS: From 2011 to 2013 we treated 56 patients with non-metastatic hormone-naïve PC. Intermittent hormonal treatment with flutamide at a dose of 250 mg 3 times per day with nine monthly injections of luteinizing gonadotropic releasing hormone (LGnRH) ["treatment" period] followed by period of observance ("no treatment") was administered. We evaluated the BMD of lumbar spine and both proximal thighs by means of dual-energy x-ray densitometry at the end of "treatment" period and at the end of "no treatment" period. RESULTS: During the first treatment period, 44 of 56 patients (78.6%) experienced the reduction in BMD in both lumbar spine and thighs. Total testosterone level in all patients dropped to castration level. During the first period of "no treatment" there was an increase in BMD (p < 0.05) in 30 (68.2%) of 44 patients. The median time to recovery of total testosterone level to the level > 50 ng/dl was 91 days (from 30 to 308 days), and > 100 ng/dl was 110 days (from 49 to 343 days). The changes in BMD positively correlated with the changes in total testosterone level (correlation 0.18 [95% CI, 0.04-0.27], p = 0.009). The decline in total testosterone level in serum was followed by the decline in BMD value in the studied areas, and vice versa. CONCLUSIONS: The changes in BMD positively correlated with changes in total testosterone level. The BMD decreases during the androgen suppression and increases during the pause in the treatment. This demonstrates the benefit of intermittent AST in preventing osteoporosis, pathological bone fractures and possibly, bone metastases.


Assuntos
Antagonistas de Androgênios/uso terapêutico , Antineoplásicos Hormonais/uso terapêutico , Densidade Óssea/efeitos dos fármacos , Neoplasias da Próstata/tratamento farmacológico , Idoso , Idoso de 80 Anos ou mais , Antagonistas de Androgênios/farmacologia , Antineoplásicos Hormonais/farmacologia , Doenças Ósseas Metabólicas/etiologia , Flutamida/uso terapêutico , Humanos , Masculino , Pessoa de Meia-Idade , Neoplasias da Próstata/complicações , Neoplasias da Próstata/metabolismo , Testosterona/antagonistas & inibidores , Testosterona/metabolismo
3.
Klin Khir ; (9): 60-3, 2013 Sep.
Artigo em Ucraniano | MEDLINE | ID: mdl-24501932

RESUMO

For the purpose of definition of characteristic morphological changes of testicular tissue which to be surveyed as precancerous, the peritumoral tissue at 40 patients with testicular germ cell tumors (TGCT) which has been spent orchiectomy is investigated and the diagnosis according to classification TNM is established. In peritumoral tissue in 95% patients with testicular germ cell tumors disturbance of spermatogenesis, characteristic for the secretory form of male infertility, are taped. Occurrence of atypical germ cells (TIN) in semen tubules, which were defined in 60% of cases, and overexpressed hyperplasia of Leydig cells of interstition, defined in 82.5% of cases--the typical changes of peritumoral testicular tissue which can be characterised as precancerous changes. Patients with the secretory form of male infertility whith atypical germ cells (TIN) in semen tubules and the overexpressed hyperplasia of Leydig cells, make hight risk group of development of testicular cancer and demand a dispensary observation.


Assuntos
Neoplasias Embrionárias de Células Germinativas/cirurgia , Lesões Pré-Cancerosas/cirurgia , Neoplasias Testiculares/cirurgia , Testículo/patologia , Testículo/cirurgia , Adolescente , Adulto , Transformação Celular Neoplásica , Humanos , Células Intersticiais do Testículo/patologia , Masculino , Pessoa de Meia-Idade , Neoplasias Embrionárias de Células Germinativas/patologia , Orquiectomia , Lesões Pré-Cancerosas/patologia , Túbulos Seminíferos/patologia , Espermatogênese , Neoplasias Testiculares/patologia , Adulto Jovem
6.
Lik Sprava ; (11-12): 49-52, 1992.
Artigo em Russo | MEDLINE | ID: mdl-1292221

RESUMO

3-OAK antigen was determined by immunodiffusion in agar by means of immune sera containing antibodies against 3-OAK. In patients with cancer of the urinary bladder the percentage of detecting 3-OAK-Ag in the native serum was 76.9 while in lyophilized it was 41.9. In patients with pretumorous diseases (leukoplakia, chronic cystitis, papillomas) their values were 64.1 and 56.1 respectively. It is concluded that lyophilized blood serum may be used in the clinical practice for immunological and serological examinations.


Assuntos
Ácido 3-Hidroxiantranílico , Antígenos de Neoplasias/sangue , Biomarcadores Tumorais/sangue , Leucoplasia/diagnóstico , Papiloma/diagnóstico , Lesões Pré-Cancerosas/diagnóstico , Neoplasias da Bexiga Urinária/diagnóstico , Liofilização , Humanos , Imunodifusão
SELEÇÃO DE REFERÊNCIAS
DETALHE DA PESQUISA
...